4//SEC Filing
Lane Michael 4
Accession 0000874716-25-000125
CIK 0000874716other
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 8:37 PM ET
Size
16.8 KB
Accession
0000874716-25-000125
Insider Transaction Report
Form 4
Lane Michael
Executive Vice President
Transactions
- Sale
Common Stock
2025-08-06$628.89/sh−300$188,666→ 7,131.944 total - Exercise/Conversion
Common Stock
2025-08-06$206.94/sh+1,286$266,125→ 8,417.944 total - Exercise/Conversion
Common Stock
2025-08-06$288.78/sh+7,125$2,057,557→ 15,542.944 total - Sale
Common Stock
2025-08-06$627.56/sh−5,631$3,533,810→ 9,911.944 total - Sale
Common Stock
2025-08-06$627.99/sh−2,480$1,557,418→ 7,431.944 total - Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2025-08-06−7,125→ 0 totalExercise: $288.78Exp: 2030-02-13→ Common Stock (7,125 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2025-08-06−1,286→ 0 totalExercise: $206.94Exp: 2029-02-13→ Common Stock (1,286 underlying)
Holdings
- 592(indirect: By Spouse)
Common Stock
Footnotes (7)
- [F1]Includes a total of 28.7090 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025.
- [F2]Represents the weighted average price of the shares sold ranging from a low of $626.70 to a high of $627.69 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- [F3]Represents the weighted average price of the shares sold ranging from a low of $627.70 to a high of $628.62 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- [F4]Represents the weighted average price of the shares sold ranging from a low of $628.82 to a high of $628.94 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- [F5]Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
- [F6]Grant of option to buy 8,366 shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2020.
- [F7]Grant of option to buy 7,125 shares of Issuer common stock that became exercisable in four annual installments beginning February 14, 2021.
Documents
Issuer
IDEXX LABORATORIES INC /DE
CIK 0000874716
Entity typeother
Related Parties
1- filerCIK 0001740689
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 8:37 PM ET
- Size
- 16.8 KB